MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Sleep disorders. See also Restless legs syndrome: Treatment"

  • 2023 International Congress

    Characterization of at-home sleep macrostructure in Parkinson disease using a wearable sleep monitoring device

    J. Thompson, L. Hirt, D. Kern, A. Baumgartner (AURORA, USA)

    Objective: Determine the viability of a wearable reduced montage EEG device to record sleep in a population of patients with Parkinson disease (PD). Background: Sleep…
  • 2023 International Congress

    Enhancement of deep sleep in people with Parkinson disease using auditory stimulation of slow waves at home

    SJ. Schreiner, S. Fattinger, J. Horlacher, G. da Poian, L. Kämpf, L. Brogli, W. Karlen, R. Huber, CR. Baumann, A. Maric (Zurich, Switzerland)

    Objective: To test the feasibility and effectivity of a new method for non-pharmacological enhancement of deep sleep in Parkinson disease (PD). Background: Sleep-wake disturbances and…
  • 2022 International Congress

    STN-DBS Targeting SNr Modulates Sleep in Parkinson’s Disease: A Proof-of-Concept Study

    HL. Yu, LX. Guan, YN. Sui, F. Ba, LM. Li (Beijing, China)

    Objective: To explore how subthalamic deep brain stimulation (STN-DBS) targeting substantia nigra pars reticulata (SNr) can modulate sleep in Parkinson’s disease (PD) patients with electrophysiologic…
  • MDS Virtual Congress 2021

    Safinamide Improves Sleep and Daytime Sleepiness in Parkinson´s Disease. Results from the SAFINONMOTOR Study

    I. Cabo López, C. Labandeira Guerra, R. Yáñez Baña, MI. Cimas Hernando, JM. Paz González, MG. Alonso Losada, MJ. González Palmás, C. Martínez Miró, D. Santos García (Pontevedra, Spain)

    Objective: Our aim was to analyze the effectiveness of safinamide on sleep in Parkinson´s disease (PD) patients from the SAFINONMOTOR (an open-label study of the…
  • MDS Virtual Congress 2021

    Effects of low frequency repetitive transcranial stimulation over right dorsolateral prefrontal region on clinical symptoms and sleep structure of Parkinson’s disease Abstract

    WU. Jing, C. Jing, Z. Sheng, LIU. Feng (Suzhou, China)

    Objective: We aim to investigate the effects of low-frequency rTMS over the dorsolateral prefrontal cortex (DLPFC) on sleep and other symptoms in PD patients. Background:…
  • MDS Virtual Congress 2021

    EFFECTIVENESS OF NEUROFUNCTIONAL PHYSICAL THERAPY ON THE QUALITY OF SLEEP OF INDIVIDUALS WITH PARKINSON’S DISEASE: A SERIES OF CASES

    R. Souza, S. Smaili, I. Almeida, M. Terra, N. Barboza, ME. Bueno, A. Mesas (Londrina, Brazil)

    Objective: To verify the effectiveness of neurofunctional physical therapy in sleep quality objectively and subjectively assess it among individuals with PD. Background: Parkinson's disease (PD)…
  • 2019 International Congress

    Prolonged-release Melatonin for Sleep Disorders in Parkinson’s Disease: A Randomized trial

    JH. Ahn, M. Kim, JK. Mun, J. Youn, S. Park, W. Jang, J. Park, E. Oh, JW. Cho, JS. Kim (Seoul, Republic of Korea)

    Objective: To evaluate the efficacy of PRM in sleep disorders of patients with PD was investigated. Background: Sleep disorders are highly prevalent in patients with…
  • 2019 International Congress

    Effect of Speech therapy in the sleep of patients with Machado-Joseph disease (MJD) or spinocerebellar ataxia type 3 (SCA3)

    G. Diaféria, JL. Pedroso, S. Park, F. Haddad, L. Haddad, L. Prado, G. Prado, O. Barsottini (São Paulo, Brazil)

    Objective: The objective of this study was to evaluate, through polysomnography, the effect of myofunctional therapy in patients with spinocerebellar ataxia type 3. Background: SCA3/MJD…
  • 2019 International Congress

    An Internet of Things system for patient empowerment: a case study on measuring patients’ understanding of causal relationships between symptoms and behaviour

    L. Karni, M. Memedi, E. Kolkowska, I. Scandurra, P. de Roos, DA. Nyholm, G. Klein (Örebro, Sweden)

    Objective: To evaluate the ability of patients to understand causal relationships between disease symptoms and behaviour presented from synthetic representative cases using the system. Secondary…
  • 2019 International Congress

    Evaluation of the Zeez Sleep Pebble for Sleep Disturbance in Parkinson’s Disease

    S. Milne, S. Cummins, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate the effect of the Zeez Sleep Pebble© on sleep disturbance in Parkinson’s disease. Background: Sleep disturbance is common in Parkinson’s disease (PD)…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley